first glp 1 agonist Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment What are GLP-1s? | Mendinground

P.DruartC.BindelsL

By 2013 five such drugs had been approved for the US market

Lancet 381: 117124

In practice, all too often nutrition and lifestyle are an afterthoughtor even ignored

25 Given concerns that skeletal muscle loss may predispose patients to long-term metabolic complications, including sarcopenia, it is recommended that individuals undergoing treatment with GLP-1 RAs receive adequate protein intake and appropriate micronutrient supplementation to preserve muscle mass and function, thereby maximizing the clinical benefits of therapy

Consistent use is associated with fewer adverse events than intermittent use